Israel Englander Opgen Inc Transaction History

Millennium Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $62.0 $1,356 - $700,848	11,304 New	11,304 $2,000
Q2 2022 Aug 15, 2022	SELL	$0.32 - $0.79 $46,632 - $115,122	-145,725 Reduced 85.74%	24,234 $13,000
Q1 2022 May 16, 2022	SELL	$0.72 - $1.11 $48,692 - $75,067	-67,628 Reduced 28.46%	169,959 $127,000
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.94 $237,587 - $698,505	237,587 New	237,587 $238,000
Q3 2021 Nov 15, 2021	SELL	$2.18 - $3.58 $76,670 - $125,908	-35,170 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.95 - $2.8 $68,581 - $98,476	35,170 New	35,170 $80,000
Q1 2021 May 17, 2021	SELL	$1.8 - $3.55 $39,439 - $77,784	-21,911 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.7 - $2.47 $37,248 - $54,120	21,911 New	21,911 $45,000
Q2 2020 Aug 14, 2020	SELL	$1.88 - $2.59 $134,792 - $185,697	-71,698 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$1.14 - $4.04 $39,359 - $139,485	-34,526 Reduced 32.5%	71,698 $183,000
Q4 2019 Feb 14, 2020	BUY	$1.02 - $7.18 $108,348 - $762,688	106,224 New	106,224 $120,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.